From the Department of Preventive Medicine (D.-H.L.), School of Medicine, Kyungpook National University, Daegu; BK21 Plus KNU Biomedical Convergence Program (D.-H.L.), Department of Biomedical Science, Kyungpook National University, Korea; Hospital del Mar Institute of Medical Research (IMIM) (M.P.), School of Medicine, Universitat Autonoma de Barcelona, and CIBERESP, Spain; Department of Medical Sciences, Cardiovascular Epidemiology (L.L.), and Department of Medical Sciences, Occupational and Environmental Medicine (P.M.L.), Uppsala University, Sweden; and Division of Epidemiology and Community Health (D.R.J.), School of Public Health, University of Minnesota, Minneapolis.
Neurology. 2018 Jan 23;90(4):176-182. doi: 10.1212/WNL.0000000000004851.
Midlife obesity is associated with increased risk of dementia, whereas late-life obesity is commonly associated with a lower risk of dementia. Although methodologic issues are often discussed in this apparent risk reversal, chronic exposure to low-dose organochlorine pesticides (OCPs), an emerging risk factor for dementia in general populations, may contribute to a direct explanation for these differences. OCPs are strong lipophilic chemicals with very long half-lives (several years), primarily stored in adipose tissue and very slowly released and metabolized over years. As serum concentrations of neurotoxic OCPs strongly correlate with brain OCPs ( = 0.95), any condition enhancing the release of OCPs from the adipose tissue into circulation would increase the risk of dementia. Increased release of OCPs from adipose tissue typically occurs in (1) dysfunctional adipocytes accompanied by uncontrolled lipolysis and (2) weight loss. Weight gain may help sequester circulating OCPs in adipose tissue. As obesity is the most common reason that adipocytes become dysfunctional, midlife obesity can increase dementia risk through the chronic release of OCPs into circulation. However, late-life obesity potentially decreases dementia risk because weight loss after midlife will increase the release of OCPs while weight gain may actually decrease the release. These countervailing forces may underlie paradoxical associations with dementia of obesity in midlife vs late life which is influenced by weight change after midlife. This hypothesis should be tested in future experimental and human studies on obesity and dementia.
中年肥胖与痴呆风险增加相关,而老年肥胖通常与痴呆风险降低相关。尽管在这种明显的风险逆转中经常讨论方法学问题,但慢性暴露于有机氯农药(OCPs)会导致痴呆的一个新兴风险因素,这可能有助于直接解释这些差异。OCPs 是一种很强的亲脂性化学物质,具有非常长的半衰期(数年),主要储存在脂肪组织中,并在数年内缓慢释放和代谢。由于神经毒性 OCPs 的血清浓度与大脑 OCPs 强烈相关(= 0.95),任何增强 OCPs 从脂肪组织释放到循环中的情况都会增加痴呆的风险。OCPs 从脂肪组织中的释放通常发生在(1)功能失调的脂肪细胞伴随着不受控制的脂肪分解和(2)体重减轻。体重增加可能有助于将循环中的 OCPs 隔离在脂肪组织中。由于肥胖是脂肪细胞功能失调最常见的原因,中年肥胖会通过将 OCPs 慢性释放到循环中而增加痴呆的风险。然而,老年肥胖可能会降低痴呆的风险,因为中年后体重减轻会增加 OCPs 的释放,而体重增加实际上可能会减少释放。这些相互矛盾的力量可能是中年和老年肥胖与痴呆之间存在矛盾关联的基础,这种关联受到中年后体重变化的影响。这个假设应该在未来关于肥胖和痴呆的实验和人体研究中进行测试。